Pediatric Peritoneal Epithelial Malignant Mesothelioma Case Report
暂无分享,去创建一个
[1] I. Wistuba,et al. Efficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma. , 2021, Cancer discovery.
[2] F. Galateau-Sallé,et al. Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Rumors (EXPeRT) contribution. , 2020, European journal of cancer.
[3] F. Varlet,et al. Multicystic and diffuse malignant peritoneal mesothelioma in children , 2020, Pediatric blood & cancer.
[4] Ying-ying Gu,et al. Role of p16 deletion and BAP1 loss in the diagnosis of malignant mesothelioma. , 2018, Journal of thoracic disease.
[5] D. Labow,et al. Malignant peritoneal mesothelioma: a review. , 2017, Annals of translational medicine.
[6] K. Frazer,et al. BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma , 2015, Journal of Translational Medicine.
[7] M. Hosoya,et al. Malignant peritoneal mesothelioma in a child: chemotherapy with gemcitabine and platinum was effective for the disease unresponsive to other treatments. , 2014, Anti-cancer drugs.
[8] N. Cox,et al. Germline BAP1 mutations predispose to malignant mesothelioma , 2011, Nature Genetics.
[9] Wengen Chen,et al. The role of PET/CT in the management of peritoneal mesothelioma , 2011 .
[10] R. Low,et al. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging. , 1994, AJR. American journal of roentgenology.
[11] D. Brenner,et al. CT of peritoneal mesothelioma: analysis of eight cases. , 1982, AJR. American journal of roentgenology.
[12] H. Pass,et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. , 2015, Carcinogenesis.
[13] C. Paidas,et al. Malignant peritoneal mesothelioma in a pediatric patient mimicking inflammatory bowel disease. , 2004, Digestive diseases and sciences.